{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T22:26:48Z","timestamp":1794090408662,"version":"4.8.0"},"reference-count":97,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"bluebird bio","id":[{"id":"https:\/\/ror.org\/04vaq9436","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.clinthera.2019.12.003","type":"journal-article","created":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T08:00:59Z","timestamp":1577174459000},"page":"322-337.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":101,"title":["Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent \u03b2-Thalassemia"],"prefix":"10.1016","volume":"42","author":[{"given":"Marissa","family":"Betts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick A.","family":"Flight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. Clark","family":"Paramore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Du\u0161an","family":"Milenkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujit","family":"Sheth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2019.12.003_bib1","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2017.018","article-title":"beta-Thalassemia Distribution in the Old World: an ancient disease seen from a historical standpoint","volume":"9","author":"De Sanctis","year":"2017","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib2","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1056\/NEJMe1802169","article-title":"Gene therapy as a curative option for beta-thalassemia","volume":"378","author":"Biffi","year":"2018","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.12.003_bib3","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/1750-1172-5-11","article-title":"Beta-thalassemia","volume":"5","author":"Galanello","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib4","author":"Muncie"},{"key":"10.1016\/j.clinthera.2019.12.003_bib5","series-title":"Guidelines For the Management Of Transfusion Dependent Thalassaemia (TDT). Nicosia, Cyprus","year":"2014"},{"key":"10.1016\/j.clinthera.2019.12.003_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM199608083350601","article-title":"Bone marrow transplantation for sickle cell disease","volume":"335","author":"Walters","year":"1996","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.12.003_bib7","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1182\/blood.V93.4.1164","article-title":"Bone marrow transplantation in adult thalassemic patients","volume":"93","author":"Lucarelli","year":"1999","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib8","doi-asserted-by":"crossref","first-page":"164","DOI":"10.5045\/kjh.2010.45.3.164","article-title":"Early central nervous system complications after allogeneic hematopoietic stem cell transplantation in children","volume":"45","author":"Koh","year":"2010","journal-title":"The Korean J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib9","first-page":"1918","article-title":"Impact of bone marrow transplantation for symptomatic sickle cell disease: an interim report","volume":"95","author":"Walters","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib10","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1182\/blood-2007-03-079665","article-title":"Long-term results of related myeloablative stem-cell transplantation to cure sickle cell disease","volume":"110","author":"Bernaudin","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib11","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3324\/haematol.2013.099747","article-title":"Hematopoietic stem cell transplantation in thalassemia major and sickle cell disease: indications and management recommendations from an international expert panel","volume":"99","author":"Angelucci","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib12","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/bmt.2015.293","article-title":"Hemopoietic stem cell transplantation in thalassemia: a report from the European society for blood and bone marrow transplantation hemoglobinopathy registry, 2000-2010","volume":"51","author":"Baronciani","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.clinthera.2019.12.003_bib13","doi-asserted-by":"crossref","first-page":"a011825","DOI":"10.1101\/cshperspect.a011825","article-title":"Hematopoietic stem cell transplantation in thalassemia and sickle cell anemia","volume":"2","author":"Lucarelli","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.clinthera.2019.12.003_bib14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.3324\/haematol.2013.083634","article-title":"International survey of T2* cardiovascular magnetic resonance in \u03b2-thalassemia major","volume":"98","author":"Carpenter","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib15","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.ijcard.2014.09.139","article-title":"Different patterns of myocardial iron distribution by whole-heart T2* magnetic resonance as risk markers for heart complications in thalassemia major","volume":"177","author":"Meloni","year":"2014","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib16","series-title":"A Short Guide for the Management of Transfusion Dependent Thalassaemia (TDT)","author":"Thalassaemia International Federation","year":"2014"},{"key":"10.1016\/j.clinthera.2019.12.003_bib17","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3324\/haematol.2009.018051","article-title":"Complications and treatment of patients with beta-thalassemia in France: results of the National Registry","volume":"95","author":"Thuret","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib18","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jpeds.2010.04.064","article-title":"Relationship between chronic transfusion therapy and body composition in subjects with thalassemia","volume":"157","author":"Fung","year":"2010","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.clinthera.2019.12.003_bib19","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1111\/bjh.12177","article-title":"Pain in thalassaemia: the effects of age on pain frequency and severity","volume":"160","author":"Haines","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib20","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1111\/trf.12348","article-title":"Transfusion complications in thalassemia patients: a report from the centers for disease control and prevention (CME)","volume":"54","author":"Vichinsky","year":"2014","journal-title":"Transfusion"},{"key":"10.1016\/j.clinthera.2019.12.003_bib21","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1056\/NEJM199807023390102","article-title":"Prevention of a first stroke by transfusions in children with sickle cell anemia and abnormal results on transcranial Doppler ultrasonography","volume":"339","author":"Adams","year":"1998","journal-title":"New Engl J Med"},{"key":"10.1016\/j.clinthera.2019.12.003_bib22","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/ajh.21317","article-title":"High nontransferrin bound iron levels and heart disease in thalassemia major","volume":"84","author":"Piga","year":"2009","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib23","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1532-429X-13-8","article-title":"Low prevalence of fibrosis in thalassemia major assessed by late gadolinium enhancement cardiovascular magnetic resonance","volume":"13","author":"Kirk","year":"2011","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.clinthera.2019.12.003_bib24","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/bjh.12340","article-title":"Assessment and management of iron overload in beta-thalassaemia major patients during the 21st century: a real-life experience from the Italian WEBTHAL project","volume":"161","author":"Piga","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib25","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1111\/j.1537-2995.2008.01775.x","article-title":"Disparity in the management of iron overload between patients with sickle cell disease and thalassemia who received transfusions","volume":"48","author":"Fung","year":"2008","journal-title":"Transfusion"},{"key":"10.1016\/j.clinthera.2019.12.003_bib26","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1159\/000338825","article-title":"Determinants of pulmonary hypertension in patients with beta-thalassemia major and normal ventricular function","volume":"128","author":"Vlahos","year":"2012","journal-title":"Acta haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0172147","article-title":"Cardiac iron overload in chronically transfused patients with thalassemia, sickle cell anemia, or myelodysplastic syndrome","volume":"12","author":"de Montalembert","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2019.12.003_bib28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4103\/2230-8210.183456","article-title":"Endocrine profile of beta-thalassemia major patients followed from childhood to advanced adulthood in a tertiary care center","volume":"20","author":"De Sanctis","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/j.clinthera.2019.12.003_bib29","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ejechocard\/jeq190","article-title":"Clinical management of cardiovascular complications in patients with thalassaemia major: a large observational multicenter study","volume":"12","author":"Derchi","year":"2011","journal-title":"Eur J echocardiography: J Working Group Echocardiography Eur Soc Cardiol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1002\/ajh.20809","article-title":"Morbidity and mortality in chronically transfused subjects with thalassemia and sickle cell disease: a report from the multi-center study of iron overload","volume":"82","author":"Fung","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/j.1600-0609.2010.01449.x","article-title":"Patterns of liver iron accumulation in patients with sickle cell disease and thalassemia with iron overload","volume":"85","author":"Hankins","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.3324\/haematol.2009.012393","article-title":"Pregnancy and beta-thalassemia: an Italian multicenter experience","volume":"95","author":"Origa","year":"2010","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib33","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1002\/jmri.21707","article-title":"Assessment of iron distribution between liver, spleen, pancreas, bone marrow, and myocardium by means of R2 relaxometry with MRI in patients with beta-thalassemia major","volume":"29","author":"Papakonstantinou","year":"2009","journal-title":"J\u00a0Magn Reson Imaging JMRI"},{"key":"10.1016\/j.clinthera.2019.12.003_bib34","doi-asserted-by":"crossref","first-page":"2777","DOI":"10.1007\/s00261-015-0461-5","article-title":"MR imaging of spleen in beta-thalassemia major","volume":"40","author":"Papakonstantinou","year":"2015","journal-title":"Abdom Imaging"},{"key":"10.1016\/j.clinthera.2019.12.003_bib35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/jmri.24752","article-title":"Pancreatic iron and fat assessment by MRI-R2* in patients with iron overload diseases","volume":"42","author":"Pfeifer","year":"2015","journal-title":"J\u00a0Magn Reson Imaging : JMRI"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2019.12.003_bib36","first-page":"s124","article-title":"Extramedullary haematopoiesis correlates with genotype and absence of cardiac iron overload in polytransfused adults with thalassaemia","volume":"12","author":"Ricchi","year":"2014","journal-title":"Blood Transfusion\u00a0= Trasfusione Del Sangue"},{"key":"10.1016\/j.clinthera.2019.12.003_bib37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.3748\/wjg.14.1559","article-title":"Prevalence of anti-HAV antibodies in multitransfused patients with beta-thalassemia","volume":"14","author":"Siagris","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib38","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2011.08576.x","article-title":"Red cell alloimmunization in a diverse population of transfused patients with thalassaemia","volume":"153","author":"Thompson","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib39","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1111\/j.1600-0609.2009.01218.x","article-title":"Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit","volume":"82","author":"Chouliaras","year":"2009","journal-title":"Eur J Haematol"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2019.12.003_bib40","first-page":"158","article-title":"Hypogonadism, diabetes mellitus, hypothyroidism, hypoparathyroidism: incidence and prevalence related to iron overload and chelation therapy in patients with thalassaemia major followed from 1980 to 2007 in the Ferrara Centre","volume":"6","author":"Gamberini","year":"2008","journal-title":"Pediatr Endocrinol Rev PER"},{"key":"10.1016\/j.clinthera.2019.12.003_bib41","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1182\/blood.V126.23.2159.2159","article-title":"Deferiprone has a dose-dependent effect on liver iron concentration","volume":"126","author":"Pepe","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib42","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02983992","article-title":"Comparison of effects of different long-term iron-chelation regimens on myocardial and hepatic iron concentrations assessed with T2* magnetic resonance imaging in patients with beta-thalassemia major","volume":"86","author":"Perifanis","year":"2007","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib43","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/ejh.12224","article-title":"History of myocardial iron loading is a strong risk factor for diabetes mellitus and hypogonadism in adults with beta thalassemia major","volume":"92","author":"Ang","year":"2014","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib44","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1002\/ajh.23543","article-title":"Tissue iron evaluation in chronically transfused children shows significant levels of iron loading at a very young age","volume":"88","author":"Berdoukas","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib45","first-page":"291","article-title":"Pericardial effusion is a marker of increased cardiac mortality in thalassemia major patients","volume":"100","author":"Meloni","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib46","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/j.echo.2012.07.007","article-title":"Left ventricular rotational dynamics in beta thalassemia major: a speckle-tracking echocardiographic study","volume":"25","author":"Monte","year":"2012","journal-title":"J\u00a0Am Soc Echocardiography: Off Publ Am Soc Echocardiogr"},{"key":"10.1016\/j.clinthera.2019.12.003_bib47","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1002\/ajh.21456","article-title":"Patterns of hepatic iron distribution in patients with chronically transfused thalassemia and sickle cell disease","volume":"84","author":"Ghugre","year":"2009","journal-title":"Am J Hematol"},{"issue":"8","key":"10.1016\/j.clinthera.2019.12.003_bib48","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1007\/s10554-008-9332-2","article-title":"Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and b-thalassemia major","volume":"24","author":"Mavrogeni","year":"2008","journal-title":"The Int J Cardiovasc Imaging"},{"key":"10.1016\/j.clinthera.2019.12.003_bib49","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.ijcard.2008.01.047","article-title":"Cardiovascular involvement in patients with beta-thalassemia major without cardiac iron overload","volume":"134","author":"Stakos","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib50","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/ajh.23844","article-title":"Endocrine function and bone disease during long-term chelation therapy with deferasirox in patients with beta-thalassemia major","volume":"89","author":"Casale","year":"2014","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib51","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1097\/MPH.0b013e3182431ddb","article-title":"Bone health evaluation of children and adolescents with homozygous beta-thalassemia: implications for practice","volume":"34","author":"Doulgeraki","year":"2012","journal-title":"J\u00a0Pediatr Hematol Oncol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib52","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/ajh.23376","article-title":"Comparison of biventricular dimensions and function between pediatric sickle-cell disease and thalassemia major patients without cardiac iron","volume":"88","author":"Meloni","year":"2013","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib53","first-page":"2277","article-title":"Relationship among chelator adherence, change in chelators, and quality of life in thalassemia","volume":"23","author":"Trachtenberg","year":"2014","journal-title":"Qual Life Res Int J Qual Life aspects Treat Care Rehabil"},{"key":"10.1016\/j.clinthera.2019.12.003_bib54","first-page":"1401829","article-title":"Anti-thyroid peroxidase antibodies and male gender are associated with diabetes occurrence in patients with beta-thalassemia major","volume":"2016","author":"Pes","year":"2016","journal-title":"J\u00a0Diabetes Res"},{"key":"10.1016\/j.clinthera.2019.12.003_bib55","first-page":"4","article-title":"Managing the patient with haemoglobinopathy and multiple red cell antibodies","volume":"109","author":"Politis","year":"2015","journal-title":"Vox Sanguinis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib56","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/ajh.24139","article-title":"Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients","volume":"90","author":"Ricchi","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib57","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/trf.13440","article-title":"Class I and II HLA antibodies in pediatric patients with thalassemia major","volume":"56","author":"Yee","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.clinthera.2019.12.003_bib58","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1007\/s00277-010-1007-0","article-title":"Endocrine and bone disease in appropriately treated adult patients with beta-thalassemia major","volume":"89","author":"Baldini","year":"2010","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib59","first-page":"1","article-title":"Complications pattern and burden of the disease in patients affected by beta-thalassaemia major","author":"Bonifazi","year":"2017","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2019.12.003_bib60","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1007\/s00277-012-1480-8","article-title":"Cardiac iron removal and functional cardiac improvement by different iron chelation regimens in thalassemia major patients","volume":"91","author":"Cassinerio","year":"2012","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib61","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1007\/s00277-014-2291-x","article-title":"A\u00a05-year follow-up in deferasirox treatment: improvement of cardiac and hepatic iron overload and amelioration in cardiac function in thalassemia major patients","volume":"94","author":"Cassinerio","year":"2015","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib62","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2016.022","article-title":"Clinical and biochemical data of adult thalassemia major (TM) patients with multiple endocrine complications (MEC) versus TM patients with normal endocrine functions: a long-term retrospective study (40 years) in a tertiary care center in Italy","volume":"8","author":"De Sanctis","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib63","doi-asserted-by":"crossref","DOI":"10.4084\/mjhid.2016.001","article-title":"Acquired hypogonadotropic hypogonadism (AHH) in thalassaemia major patients: an underdiagnosed condition?","volume":"8","author":"De Sanctis","year":"2016","journal-title":"Mediterr J Hematol Infect Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib64","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.bcmd.2013.04.002","article-title":"Long-term treatment with deferiprone enhances left ventricular ejection function when compared to deferoxamine in patients with thalassemia major","volume":"51","author":"Filosa","year":"2013","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib65","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3109\/03630269.2010.485071","article-title":"Incidence of hepatocellular carcinoma in a thalassemia unit","volume":"34","author":"Fragatou","year":"2010","journal-title":"Hemoglobin"},{"key":"10.1016\/j.clinthera.2019.12.003_bib66","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.bbmt.2012.08.005","article-title":"French multicenter 22-year experience in stem cell transplantation for beta-thalassemia major: lessons and future directions","volume":"19","author":"Galambrun","year":"2013","journal-title":"Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant"},{"key":"10.1016\/j.clinthera.2019.12.003_bib67","first-page":"231","article-title":"Changes in the quality of life of people with thalassemia major between 2001 and 2009","volume":"7","author":"Gollo","year":"2013","journal-title":"Patient preference and adherence"},{"key":"10.1016\/j.clinthera.2019.12.003_bib68","first-page":"420","article-title":"Liver disease in adult transfusion-dependent beta-thalassaemic patients: investigating the role of iron overload and chronic HCV infection","volume":"33","author":"Kountouras","year":"2013","journal-title":"Liver Int official J Int Assoc Study Liver"},{"key":"10.1016\/j.clinthera.2019.12.003_bib69","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.bcmd.2010.05.005","article-title":"Increased survival and reversion of iron-induced cardiac disease in patients with thalassemia major receiving intensive combined chelation therapy as compared to desferoxamine alone","volume":"45","author":"Lai","year":"2010","journal-title":"Blood Cells Mol Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib70","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1111\/ejh.12086","article-title":"Natural history of hepatitis C in thalassemia major: a long-term prospective study","volume":"90","author":"Lai","year":"2013","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib71","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1002\/ajh.23219","article-title":"Long-term use of deferiprone significantly enhances left-ventricular ejection function in thalassemia major patients","volume":"87","author":"Maggio","year":"2012","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib72","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.bcmd.2014.11.003","article-title":"Pulmonary hypertension in well-transfused thalassemia major patients","volume":"54","author":"Meloni","year":"2015","journal-title":"Blood Cell Mol Dis"},{"key":"10.1016\/j.clinthera.2019.12.003_bib73","doi-asserted-by":"crossref","first-page":"583","DOI":"10.3324\/haematol.10842","article-title":"Liver iron concentrations and urinary hepcidin in beta-thalassemia","volume":"92","author":"Origa","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.clinthera.2019.12.003_bib74","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1002\/pbc.21275","article-title":"Serum ferritin underestimates liver iron concentration in transfusion independent thalassemia patients as compared to regularly transfused thalassemia and sickle cell patients","volume":"49","author":"Pakbaz","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.clinthera.2019.12.003_bib75","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/BF03346643","article-title":"Prevalence of growth hormone deficiency in adult polytransfused beta-thalassemia patients and correlation with transfusional and chelation parameters","volume":"33","author":"Poggi","year":"2010","journal-title":"J\u00a0endocrinological Invest"},{"key":"10.1016\/j.clinthera.2019.12.003_bib76","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-0609.2010.01447.x","article-title":"Combined chelation therapy in thalassemia major with deferiprone and desferrioxamine: a retrospective study","volume":"85","author":"Ricchi","year":"2010","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib77","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3109\/03630269.2014.905792","article-title":"Prevalence of low bone mass and vitamin D deficiency in beta-thalassemia major","volume":"38","author":"Tzoulis","year":"2014","journal-title":"Hemoglobin"},{"key":"10.1016\/j.clinthera.2019.12.003_bib78","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2141.2009.07793.x","article-title":"Differences in the prevalence of growth, endocrine and vitamin D abnormalities among the various thalassaemia syndromes in North America","volume":"146","author":"Vogiatzi","year":"2009","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib79","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/trf.13513","article-title":"Healthcare costs and outcomes of managing beta-thalassemia major over 50 years in the United Kingdom","volume":"56","author":"Weidlich","year":"2016","journal-title":"Transfusion"},{"key":"10.1016\/j.clinthera.2019.12.003_bib80","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/j.1365-2141.2008.07135.x","article-title":"Vitamin D deficiency, cardiac iron and cardiac function in thalassaemia major","volume":"141","author":"Wood","year":"2008","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib81","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1600-0609.2011.01582.x","article-title":"Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population","volume":"86","author":"Ladis","year":"2011","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib82","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1185\/03007990802160834","article-title":"Costs, quality of life, treatment satisfaction and compliance in patients with beta-thalassemia major undergoing iron chelation therapy: the ITHACA study","volume":"24","author":"Scalone","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.clinthera.2019.12.003_bib83","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.1182\/blood-2011-04-344507","article-title":"Chelation use and iron burden in North American and British thalassemia patients: a report from the Thalassemia Longitudinal Cohort","volume":"119","author":"Kwiatkowski","year":"2012","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib84","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V128.22.849.849","article-title":"Gender differences in the development of CMR abnormalities and cardiac complications: a multicentric prospective study in a large cohort of thalassemia major patients","volume":"128","author":"Pepe","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib86","doi-asserted-by":"crossref","first-page":"3278","DOI":"10.1182\/blood.V126.23.3278.3278","article-title":"Beta-thalassemia treatment and complications in two large us insured population databases","volume":"126","author":"Maserejian","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clinthera.2019.12.003_bib87","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/bjh.13009","article-title":"Hepatocellular carcinoma in thalassaemia: an update of the Italian Registry","volume":"167","author":"Borgna-Pignatti","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib88","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/j.1749-6632.2010.05583.x","article-title":"Fertility potential in thalassemia major women: current findings and future diagnostic tools","volume":"1202","author":"Singer","year":"2010","journal-title":"Ann New York Acad Sci"},{"key":"10.1016\/j.clinthera.2019.12.003_bib89","first-page":"523","article-title":"Beta-Thalassemia major and pregnancy","volume":"114","author":"Gulino","year":"2013","journal-title":"Bratislavske lekarske listy"},{"key":"10.1016\/j.clinthera.2019.12.003_bib90","first-page":"74","article-title":"Spermatogenesis in young adult patients with beta-thalassaemia major long-term treated with desferrioxamine","author":"De Sanctis","year":"2008","journal-title":"Georgian Med News"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2019.12.003_bib91","first-page":"185","article-title":"Spermatozoal DNA damage in patients with B thalassaemia syndromes","volume":"6","author":"De Sanctis","year":"2008","journal-title":"Pediatr Endocrinol Rev PER"},{"key":"10.1016\/j.clinthera.2019.12.003_bib92","first-page":"315","article-title":"Socio-psychological impact of infused iron chelation therapy with deferoxamine in metropolitan France: ISOSFER study results","volume":"14","author":"Thuret","year":"2009","journal-title":"Hematology (Amsterdam, Netherlands)"},{"key":"10.1016\/j.clinthera.2019.12.003_bib93","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1111\/j.1600-0609.2008.01054.x","article-title":"Early impairment of myocardial function in young patients with beta-thalassemia major","volume":"80","author":"Magri","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib94","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.bone.2008.03.003","article-title":"Fracture prevalence and relationship to endocrinopathy in iron overloaded patients with sickle cell disease and thalassemia","volume":"43","author":"Fung","year":"2008","journal-title":"Bone"},{"key":"10.1016\/j.clinthera.2019.12.003_bib95","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1002\/ajh.21896","article-title":"Quality of life in thalassemia: a comparison of SF-36 results from the thalassemia longitudinal cohort to reported literature and the US norms","volume":"86","author":"Sobota","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib96","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/ajh.21670","article-title":"Pain as an emergent issue in thalassemia","volume":"85","author":"Trachtenberg","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clinthera.2019.12.003_bib97","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1532-429X-10-42","article-title":"Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance","volume":"10","author":"Modell","year":"2008","journal-title":"J\u00a0Cardiovasc Magn Reson"},{"key":"10.1016\/j.clinthera.2019.12.003_bib98","doi-asserted-by":"crossref","first-page":"917","DOI":"10.3324\/haematol.12513","article-title":"Onset of cardiac iron loading in pediatric patients with thalassemia major","volume":"93","author":"Wood","year":"2008","journal-title":"Haematologica"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819305867?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291819305867?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:52:20Z","timestamp":1758963140000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291819305867"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":97,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S0149291819305867"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.12.003","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systematic Literature Review of the Burden of Disease and Treatment for Transfusion-dependent \u03b2-Thalassemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2019.12.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}